A decline in regional cerebral glucose metabolism, determined by [18F]-fluorodeoxyglucose (FDG) PET, in an AD patient 16 months before death correlated with cortical neuronal loss and with intense staining of GFAP+ cells in cortical areas at autopsy [57]. Here, GFAP is linked to Alzheimer disease.